MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-12-2026
VistaGen Therapeutics Shares 2011-2026 | VTGN
Annual Shares VistaGen Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.9 M | 19.4 M | 6.96 M | 6.89 M | 6.74 M | 43.9 M | 28.6 M | 13.9 M | 7.53 M | 1.77 M | 1.32 M | 1.1 M | 905 K | 737 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 43.9 M | 737 K | 12.2 M |
Quarterly Shares VistaGen Therapeutics
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42.2 M | 35.7 M | 31.9 M | 30.7 M | 30.6 M | 30.6 M | 29.4 M | 10 M | 7.34 M | - | 6.89 M | 6.89 M | 6.89 M | 207 M | 202 M | 195 M | 192 M | 146 M | 81.1 M | 81.1 M | 67.1 M | 51.3 M | 43.2 M | 43.2 M | 42.6 M | 42.6 M | 30.7 M | 30.7 M | 25.8 M | 22.9 M | 13.9 M | 9.89 M | 9.03 M | 9.03 M | 8.38 M | 8.38 M | 8.04 M | 5.1 M | 1.77 M | 1.62 M | 1.62 M | 1.47 M | 1.3 M | 1.3 M | 1.28 M | - | 1.11 M | 1.08 M | 1.06 M | - | 18.3 M | 17.4 M | 16.8 M | 18.7 M | 16.4 M | 15.2 M | 15.2 M | 5.24 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 207 M | 1.06 M | 36 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Compugen Ltd.
CGEN
|
93.4 M | $ 2.86 | 3.62 % | $ 267 M |  Israel |
 |
FSD Pharma
HUGE
|
38.7 M | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M |  Germany |
 |
AgeX Therapeutics
AGE
|
10.2 M | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
220 M | - | - | $ 866 M |  China |
 |
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
45.7 M | $ 0.8 | -3.59 % | $ 36.6 M | Israel |
 |
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
44.7 B | - | 2.54 % | $ 160 B | France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
4.28 M | - | - | $ 269 M | USA |
 |
Exelixis
EXEL
|
272 M | $ 46.21 | -5.11 % | $ 12.5 B | USA |
 |
Fortress Biotech
FBIO
|
27.9 M | $ 2.4 | -5.88 % | $ 67 M | USA |
 |
BioNTech SE
BNTX
|
244 M | $ 93.02 | -2.35 % | $ 27.2 B | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
|
Forte Biosciences
FBRX
|
12.9 M | $ 26.17 | -1.32 % | $ 339 M | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
21.6 M | - | - | $ 231 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
166 M | $ 22.56 | 5.03 % | $ 3.74 B | USA |
 |
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Esperion Therapeutics
ESPR
|
208 M | $ 3.14 | -0.32 % | $ 653 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.65 M | $ 3.54 | 3.51 % | $ 5.83 M | Israel |
 |
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M | Canada |
 |
Genprex
GNPX
|
933 K | $ 0.87 | -2.84 % | $ 811 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
14.3 M | - | 1.93 % | $ 17.4 M | USA |
 |
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
2.45 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
67.7 M | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | USA |
 |
Allakos
ALLK
|
86.8 M | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
15.3 M | - | 4.14 % | $ 49.1 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
127 M | $ 20.66 | -14.52 % | $ 2.63 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | USA |
 |
Genmab A/S
GMAB
|
630 M | $ 27.06 | -2.98 % | $ 16.7 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | USA |
 |
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
25.4 M | - | 10.36 % | $ 9.8 M | USA |
 |
Applied Therapeutics
APLT
|
84.2 M | - | - | $ 8.42 M | USA |
 |
Aravive
ARAV
|
36.4 M | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
18.8 M | - | 17.91 % | $ 11.1 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
89.9 M | $ 52.42 | -4.83 % | $ 4.71 B |  Schweiz |
 |
Avenue Therapeutics
ATXI
|
3.13 M | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
266 M | $ 1.61 | -5.29 % | $ 428 M | Britain |
 |
Heron Therapeutics
HRTX
|
167 M | $ 1.24 | -5.34 % | $ 207 M | USA |
 |
AVROBIO
AVRO
|
44.3 M | - | 1083.1 % | $ 745 M | USA |